Similar articles

• Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.

  Perloff M, Muggia FM, Ackerman C. Perloff M, et al. Cancer Chemother Rep. 1974 May-Jun;58(3):421-4. Cancer Chemother Rep. 1974. PMID: 4841718 No abstract available.
• A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.

  Ahmann DL, Hahn RG, Bisel HF. Ahmann DL, et al. Cancer Res. 1972 Nov;32(11):2432-4. Cancer Res. 1972. PMID: 5082592 No abstract available.
• CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.

  Hoogstraten B, Gottlieb JA, Caoili E, Tucker WG, Talley RW, Haut A. Hoogstraten B, et al. Cancer. 1973 Jul;32(1):38-43. doi: 10.1002/1097-0142(197307)32:1<38::aid-cncr2820320105>3.0.co;2-i. Cancer. 1973. PMID: 4716783 No abstract available.
• An overview of the status of the nitrosoureas in other tumors.

  Carter SK. Carter SK. Cancer Chemother Rep 3. 1973 May;4(3):35-46. Cancer Chemother Rep 3. 1973. PMID: 4584034 Review. No abstract available.
• Solid tumor chemotherapy: new drugs and horizons.

  Yardumian H. Yardumian H. J Am Osteopath Assoc. 1974 Dec;74(4):299-306. J Am Osteopath Assoc. 1974. PMID: 4140203 Review. No abstract available.